We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
-19.84%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$388M
AUM Growth
–
Cap. Flow
+$477M
Cap. Flow %
122.94%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$199M
2
AEVA
Aeva Technologies
AEVA
+$155M
3
TYRA icon
Tyra Biosciences
TYRA
+$87.6M
4
RLYB icon
Rallybio
RLYB
+$35M
5
BRDS
Bird Global, Inc.
BRDS
+$500K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 63.89%
2 Technology 36%
3 Consumer Discretionary 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
1
DELISTED
Day One Biopharmaceuticals
DAWN
$163M 41.94%
+9,663,645
New +$199M
AEVA
2
Aeva Technologies
AEVA
$1.26B
$140M 36%
+3,697,039
New +$155M
TYRA icon
3
Tyra Biosciences
TYRA
$1.91B
$62M 15.98%
+4,409,991
New +$87.6M
RLYB icon
4
Rallybio
RLYB
$84.6M
$23M 5.92%
+301,214
New +$35M
BRDS
5
DELISTED
Bird Global, Inc.
BRDS
$427K 0.11%
+2,771
New +$500K
VECT
6
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$182K 0.05%
+37,051
New +$183K

Similar funds

CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
MF
Midwestern Financial Iowa City, Iowa $127M AUM 13.96% 1-Year Est. Return
SAP
Strategic Advisory Partners Greensboro, North Carolina $127M AUM
S
Storgate Dallas, Texas $127M AUM
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
VDC
Van Diest Capital Poly City, Iowa $127M AUM
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return

Canaan Partners XI's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Canaan Partners XI, which disclosed 6 positions worth $388M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Day One Biopharmaceuticals: 9,663,645 shares worth $163M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, followed by Technology and Consumer Discretionary.

  • Canaan Partners XI's largest Q4 2021 buy was Day One Biopharmaceuticals: 9,663,645 shares worth $163M.
  • Canaan Partners XI's ten largest holdings make up 100% of its $388M portfolio in Q4 2021.
  • Canaan Partners XI disclosed 6 positions in Q4 2021, its first 13F filing on record.

Based on Canaan Partners XI's 13F filing for Q4 2021, filed 3 Feb 2022.